Eave was founded by former NHS Audiologist Dr David Greenberg to address occupational hearing loss challenges. The company’s patented technology uniquely combines real-time monitoring and reporting of noise exposure, personalised hearing protection and wireless communication into a single active ear defender product.
The headset features revolutionary ‘Hear-Through’ technology which allows wearers to be more aware of their surroundings whilst also importantly preventing deafness, the most reported occupational disease in the EU. Hearing loss is now the greatest modifiable risk factor against developing dementia.
We have been closely following EAVE’s progress since 2017 and are pleased to have invested at this exciting stage. Having worked as an NHS Clinical Audiologist and Researcher, David knew the enormity of the problem and has provided a sound solution. We look forward to working alongside David and his exceptional management team to help prevent hearing loss in the workplace and consequently, the isolation and loneliness that comes with deafness.
|Date of investment||October 2020|
|Cost of investment||£2,750,000|
|% of ownership||16.6%|
|Latest valuation of Pembroke investment||£2,166,000|